Smoking Cessation and Nicotine De-Addiction Products Market to Expand at a CAGR of 14.0% by 2023 | Global Key Players - Cipla, GlaxoSmithKline, McNeil AB, NJOY, Novartis International AG, Pfizer

Marketprognosis.com Publish a New Market Research Report On “Global Smoking Cessation and Nicotine De-Addiction Products Market 2018 - 2023” which contains global key player’s survey information and forecast to 2023.

Overview of the Global Smoking Cessation and Nicotine De-Addiction Products Market:

The Global Smoking Cessation and Nicotine De-Addiction Products Market is expected to register a CAGR of about 14.0% during the forecast period, 2018-2023.

Smoking is one of the major causes of lung cancer and other respiratory and cardiac diseases. Awareness about these health hazards has influenced individuals to adopt smoking cessation therapy. Awareness digital media, print media, and other sources of information have proved to be effective in curbing the nicotine addiction crisis to some extent.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/17148 .

Tobacco use is risky behavior among youth that extends into adulthood. Quitting smoking is beneficial to health at any age, and smokers who quit before 35 years of age have mortality rates similar to those who never smoked. Of the current 44.5 million smokers in the United States, 70% (31 M) claim they would like to quit, 70% of smokers visit a physician yearly, and 46% report an attempt to quit smoking in the past year, which leads to high usage of De-addiction products. Also, this portrays the rising awareness of the population and their willingness to quit smoking. The rise in awareness is also fueled by government efforts, such as advertisements, and distribution of educational pamphlets, etc. Also, there are non-government organizations working to educate and help people quit smoking are that are engaged dedicatedly to bring the number of smokers down. This will allow the smoking cessation and nicotine de-addiction products market to flourish during the forecast period. Other factors that will help the market to grow during the forecast period include introduction of new products and reimbursement for smoking cessation therapy.

Most adults say that they smoke because of habit or routine and/or because it helps them relax and cope with stress. Many smokers are more likely to increase their cigarette use when they’re under pressure. Certain events, such as holidays, job changes, and life transitions, can trigger certain habits, including smoking. The idea that people smoke cigarettes to help ease the signs and symptoms of stress is known as 'self-medication'. Stress is very common, affecting us when we feel unable to cope with unwelcome pressure.

Purchase this report online with 109 Pages, Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/17148 .

North America is expected to dominate the market during the forecast years, due to increasing number of smokers and growing awareness regarding health hazards associated with smoking. Asia-Pacific is expected to be the fastest growing region for the market, due to increasing awareness about the smoking cessation and nicotine de-addiction products and a huge population base in the area.

Major Key Players:

1 Cipla Ltd.

2 GlaxoSmithKline plc

3 Imperial Tobacco Company of India Limited.

4 McNeil AB

5 NJOY, Inc.

6 Novartis International AG

7 Pfizer, Inc.

8 Revolymer PLC and More……………

Any Query? Ask to our Expert @ https://marketprognosis.com/enquiry/17148 .

This study answers to the below key questions:

1 What will the market size be in 2023 and what will the growth rate be?

2 What are the key market trends?

3 What are the challenges to market growth?

4 Who are the key players in this market?

5 What are the market opportunities and threats faced by the key players?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Smoking Cessation and Nicotine De-Addiction Products Market.

Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Key Inferences

5 Market Overview

6 Drivers, Restraints, Opportunities and Challenges Analysis (Droc)

7 Market Segmentation

8 Competitive Landscape

9 Key Players

10 Future Outlook of the Market

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

sales@marketprognosis.com

+1 973 241 5193

https://www.marketprognosis.com

This release was published on openPR.